9.00
+0.155(+1.75%)
Currency In USD
| Previous Close | 8.84 |
| Open | 8.8 |
| Day High | 9.38 |
| Day Low | 8.8 |
| 52-Week High | 13.28 |
| 52-Week Low | 4.02 |
| Volume | 906,915 |
| Average Volume | 1.31M |
| Market Cap | 479.89M |
| PE | 3.43 |
| EPS | 2.62 |
| Moving Average 50 Days | 6.95 |
| Moving Average 200 Days | 7.52 |
| Change | 0.16 |
If you invested $1000 in Emergent BioSolutions Inc. (EBS) 10 years ago, it would be worth $265.1 as of August 18, 2025 at a share price of $8.995. Whereas If you bought $1000 worth of Emergent BioSolutions Inc. (EBS) shares 5 years ago, it would be worth $69.23 as of August 18, 2025 at a share price of $8.995.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
New Publication in Expert Review of Anti-infective Therapy Evaluates Brincidofovir as Potential Antiviral Treatment for Mpox
GlobeNewswire Inc.
Jul 28, 2025 12:50 PM GMT
Ongoing mpox outbreak continues to be a global health threat and is driving need for greater therapeutic research and innovationGAITHERSBURG, Md., July 28, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the publicat
Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives
GlobeNewswire Inc.
Jul 28, 2025 12:50 PM GMT
GAITHERSBURG, Md., July 28, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announces its recognition of the U.S. House of Representatives for adding over-the-counter (OTC) naloxone to every AED location in its buildings, prov
Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025
GlobeNewswire Inc.
Jul 15, 2025 11:30 AM GMT
GAITHERSBURG, Md., July 15, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, August 6, 2025, at 5:00 pm eastern time to discuss the financial results for the second quarter of 2025. Participa